Skip to main content

Navigation group

Type at least 3 characters
1,748 articles

Articles

Brief Research Report

Published on 07 Jul 2022

Antibody Response to SARS-CoV-2 Vaccination in Patients With Lymphoproliferative Disorders and Plasma Cell Dyscrasias: Anti-Lymphoma Therapy as a Predictive Biomarker of Response to Vaccination

in Hematologic Malignancies

  • Carol Gung
  • Regina McGuire
  • Mercy George
  • Abdullateef Abdulkareem
  • Katherine A. Belden
  • Pierluigi Porcu
  • Ubaldo Martinez-Outschoorn
  • Adam F. Binder
  • Inna Chervenova
  • Onder Alpdogan
Antibody Response to SARS-CoV-2 Vaccination in Patients With Lymphoproliferative Disorders and Plasma Cell Dyscrasias: Anti-Lymphoma Therapy as a Predictive Biomarker of Response to Vaccination
Frontiers in Oncology
doi 10.3389/fonc.2022.840451
  • 2,237 views
  • 4 citations